Literature DB >> 17406884

Glycoxidized particles mimic lipofuscin accumulation in aging eyes: a new age-related macular degeneration model in rabbits.

Tsutomu Yasukawa1, Peter Wiedemann, Stefan Hoffmann, Johannes Kacza, Wolfram Eichler, Yu-Sheng Wang, Akiko Nishiwaki, Johannes Seeger, Yuichiro Ogura.   

Abstract

PURPOSE: The biogenesis of drusen, a hallmark of age-related macular degeneration (AMD), is still unclear. Lipofuscin, which extensively accumulates with age in RPE cells, is hardly soluble, derived in part from oxidation byproducts of the photoreceptor outer segments. The purpose of the current study is to develop a new AMD model in rabbits using glycoxidized particles as imitation lipofuscin, and determine whether accumulation of lipofuscin as insoluble material may play a role in drusen biogenesis and other pathogenesis of AMD.
METHODS: To mimic the accumulation of insoluble lipofuscin, glycoxidized microspheres (glycox-MS) were made through a glycoxidation process with albumin and glycolaldehyde, alpha-hydroxy aldehyde. As a control, microspheres made with glutaraldehyde (cMS) and soluble glycoxidized (glycox-) albumin were prepared. Each material was implanted into the subretinal space in rabbits. The implanted area was assessed by funduscopy, fluorescein angiography, histology, and transmission electron microscopy (TEM).
RESULTS: Compared with control microspheres, glycox-MS stagnated for a prolonged period in the cytoplasm of RPE cells. Eyes implanted with glycox-MS produced drusen-like deposits at a significantly higher frequency, when compared with the controls. Glycox-MS were observed at the margin of or beneath the drusen-like deposits in all cases. In some eyes with glycox-MS, late-onset sub-RPE choroidal neovascularization was observed, while control groups did not have these findings.
CONCLUSIONS: These results suggest that the accumulation of indigestible granules such as lipofuscin in RPE or subsequent depositions toward Bruch's membrane may play a role in drusen biogenesis as a trigger of inflammation or via other mechanisms. This model of AMD may be useful to elucidate drusen biogenesis and pathogenesis of AMD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406884     DOI: 10.1007/s00417-007-0571-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  77 in total

1.  Spectroscopic and morphological studies of human retinal lipofuscin granules.

Authors:  Nicole M Haralampus-Grynaviski; Laura E Lamb; Christine M R Clancy; Christine Skumatz; Janice M Burke; Tadeusz Sarna; John D Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-28       Impact factor: 11.205

2.  Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium.

Authors:  C Schwesinger; C Yee; R M Rohan; A M Joussen; A Fernandez; T N Meyer; V Poulaki; J J Ma; T M Redmond; S Liu; A P Adamis; R J D'Amato
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Evidence against increased glycoxidation in patients with Alzheimer's disease.

Authors:  R Seidl; E Schuller; N Cairns; G Lubec
Journal:  Neurosci Lett       Date:  1997-08-22       Impact factor: 3.046

4.  Complement factor H polymorphism and age-related macular degeneration.

Authors:  Albert O Edwards; Robert Ritter; Kenneth J Abel; Alisa Manning; Carolien Panhuysen; Lindsay A Farrer
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

5.  Complement factor H variant increases the risk of age-related macular degeneration.

Authors:  Jonathan L Haines; Michael A Hauser; Silke Schmidt; William K Scott; Lana M Olson; Paul Gallins; Kylee L Spencer; Shu Ying Kwan; Maher Noureddine; John R Gilbert; Nathalie Schnetz-Boutaud; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

6.  Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation.

Authors:  D H Anderson; S Ozaki; M Nealon; J Neitz; R F Mullins; G S Hageman; L V Johnson
Journal:  Am J Ophthalmol       Date:  2001-06       Impact factor: 5.258

7.  Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells.

Authors:  G S Hageman; R F Mullins; S R Russell; L V Johnson; D H Anderson
Journal:  FASEB J       Date:  1999-03       Impact factor: 5.191

Review 8.  A role for local inflammation in the formation of drusen in the aging eye.

Authors:  Don H Anderson; Robert F Mullins; Gregory S Hageman; Lincoln V Johnson
Journal:  Am J Ophthalmol       Date:  2002-09       Impact factor: 5.258

9.  The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration.

Authors:  Lincoln V Johnson; William P Leitner; Alexander J Rivest; Michelle K Staples; Monte J Radeke; Don H Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-20       Impact factor: 11.205

10.  Experimental drusen formation induced by intravitreal aminoglycoside injection.

Authors:  C A Tabatabay; D J D'Amico; L A Hanninen; K R Kenyon
Journal:  Arch Ophthalmol       Date:  1987-06
View more
  9 in total

1.  Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits.

Authors:  Yasuhiro Nakagami; Kayoko Masuda; Emiko Hatano; Tatsuya Inoue; Takuya Matsuyama; Mayumi Iizuka; Yasunori Ono; Takashi Ohnuki; Yoko Murakami; Masaru Iwasaki; Kazuhiro Yoshida; Yuji Kasuya; Satoshi Komoriya
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

Review 2.  Retinoids for treatment of retinal diseases.

Authors:  Krzysztof Palczewski
Journal:  Trends Pharmacol Sci       Date:  2010-06       Impact factor: 14.819

Review 3.  Retinal photodamage mediated by all-trans-retinal.

Authors:  Tadao Maeda; Marcin Golczak; Akiko Maeda
Journal:  Photochem Photobiol       Date:  2012-04-24       Impact factor: 3.421

4.  Fundus autofluorescence and fate of glycoxidized particles injected into subretinal space in rabbit age-related macular degeneration model.

Authors:  Megumi Hirata; Tsutomu Yasukawa; Peter Wiedemann; Erika Kimura; Noriyuki Kunou; Wolfram Eichler; Ayae Takase; Rina Sato; Yuichiro Ogura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-03-28       Impact factor: 3.117

5.  Limited roles of Rdh8, Rdh12, and Abca4 in all-trans-retinal clearance in mouse retina.

Authors:  Akiko Maeda; Marcin Golczak; Tadao Maeda; Krzysztof Palczewski
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-06-24       Impact factor: 4.799

6.  Age and disease-related structural changes in the retinal pigment epithelium.

Authors:  Vera L Bonilha
Journal:  Clin Ophthalmol       Date:  2008-06

7.  Pemafibrate Prevents Retinal Pathological Neovascularization by Increasing FGF21 Level in a Murine Oxygen-Induced Retinopathy Model.

Authors:  Yohei Tomita; Nobuhiro Ozawa; Yukihiro Miwa; Ayako Ishida; Masayuki Ohta; Kazuo Tsubota; Toshihide Kurihara
Journal:  Int J Mol Sci       Date:  2019-11-23       Impact factor: 5.923

8.  Vitamin A cycle byproducts explain retinal damage and molecular changes thought to initiate retinal degeneration.

Authors:  Dan Zhang; Doina M Mihai; Ilyas Washington
Journal:  Biol Open       Date:  2021-11-29       Impact factor: 2.422

9.  Oxidized low-density lipoprotein causes ribosome reduction and inhibition of protein synthesis in retinal pigment epithelial cells.

Authors:  Francesco Giorgianni; Sarka Beranova-Giorgianni
Journal:  Biochem Biophys Rep       Date:  2022-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.